{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T03:36:43Z","timestamp":1772163403171,"version":"3.50.1"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004896","name":"Eisai Incorporated","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004896","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy &amp; Behavior"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.yebeh.2023.109194","type":"journal-article","created":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T04:53:37Z","timestamp":1682571217000},"page":"109194","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Anti-seizure efficacy of perampanel in two established rodent models of early-life epilepsy"],"prefix":"10.1016","volume":"143","author":[{"given":"Nicholas S.","family":"Roberts","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcus J.","family":"Handy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshimasa","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keisuke","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frances E.","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Delia M.","family":"Talos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.yebeh.2023.109194_b0005","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1684\/epd.2015.0736","article-title":"Incidence, prevalence and aetiology of seizures and epilepsy in children","volume":"17","author":"Camfield","year":"2015","journal-title":"Epileptic Disord"},{"issue":"1","key":"10.1016\/j.yebeh.2023.109194_b0010","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1528-1157.1996.tb00506.x","article-title":"Incidence of epilepsy in childhood and adolescence: a population-based study in Nova Scotia from 1977 to 1985","volume":"37","author":"Camfield","year":"1996","journal-title":"Epilepsia"},{"issue":"4","key":"10.1016\/j.yebeh.2023.109194_b0015","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/1098-2779(2000)6:4<253::AID-MRDD4>3.0.CO;2-P","article-title":"Developmental seizures induced by common early-life insults: short- and long-term effects on seizure susceptibility","volume":"6","author":"Jensen","year":"2000","journal-title":"Ment Retard Dev Disabil Res Rev"},{"issue":"1","key":"10.1016\/j.yebeh.2023.109194_b0020","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13052-018-0491-z","article-title":"Benign and severe early-life seizures: a round in the first year of life","volume":"44","author":"Pavone","year":"2018","journal-title":"Ital J Pediatr"},{"issue":"4","key":"10.1016\/j.yebeh.2023.109194_b0025","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a022749","article-title":"Epilepsy and Autism","volume":"6","author":"Buckley","year":"2016","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.yebeh.2023.109194_b0030","doi-asserted-by":"crossref","unstructured":"Worden LKT SK. Physiology and pathophysiology of seizures in the developing brain: World Scientific; 2019. 436 p.","DOI":"10.1142\/9789813277731_0002"},{"key":"10.1016\/j.yebeh.2023.109194_b0035","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.yebeh.2019.05.011","article-title":"Immediate outcomes in early life epilepsy: A contemporary account","volume":"97","author":"Berg","year":"2019","journal-title":"Epilepsy Behav"},{"issue":"7","key":"10.1016\/j.yebeh.2023.109194_b0040","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/nrneurol.2009.80","article-title":"Epileptogenesis in the immature brain: emerging mechanisms","volume":"5","author":"Rakhade","year":"2009","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"10.1016\/j.yebeh.2023.109194_b0045","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/cne.20978","article-title":"Developmental regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid receptor subunit expression in forebrain and relationship to regional susceptibility to hypoxic\/ischemic injury. II. Human cerebral white matter and cortex","volume":"497","author":"Talos","year":"2006","journal-title":"J Comp Neurol"},{"issue":"11","key":"10.1016\/j.yebeh.2023.109194_b0050","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/nm1301","article-title":"NKCC1 transporter facilitates seizures in the developing brain","volume":"11","author":"Dzhala","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.yebeh.2023.109194_b0055","doi-asserted-by":"crossref","first-page":"100","DOI":"10.3389\/fnana.2019.00100","article-title":"Developmental changes of glutamate and GABA receptor densities in Wistar rats","volume":"13","author":"Behuet","year":"2019","journal-title":"Front Neuroanat"},{"key":"10.1016\/j.yebeh.2023.109194_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2021.108585","article-title":"Kainate receptors in the developing neuronal networks","volume":"195","author":"Lauri","year":"2021","journal-title":"Neuropharmacology"},{"issue":"5","key":"10.1016\/j.yebeh.2023.109194_b0065","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1046\/j.1471-4159.2001.00329.x","article-title":"Gamma-aminobutyric acid(A) receptor subunit expression predicts functional changes in hippocampal dentate granule cells during postnatal development","volume":"77","author":"Brooks-Kayal","year":"2001","journal-title":"J Neurochem"},{"issue":"5","key":"10.1016\/j.yebeh.2023.109194_b0070","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.siny.2017.07.008","article-title":"The use of phenobarbital and other anti-seizure drugs in newborns","volume":"22","author":"El-Dib","year":"2017","journal-title":"Semin Fetal Neonatal Med"},{"issue":"9","key":"10.1016\/j.yebeh.2023.109194_b0075","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/nrn920","article-title":"Excitatory actions of GABA during development: the nature of the nurture","volume":"3","author":"Ben-Ari","year":"2002","journal-title":"Nat Rev Neurosci"},{"issue":"3","key":"10.1016\/j.yebeh.2023.109194_b0080","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/j.0953-816X.2003.03152.x","article-title":"Developmental changes in GABAergic actions and seizure susceptibility in the rat hippocampus","volume":"19","author":"Khazipov","year":"2004","journal-title":"Eur J Neurosci"},{"issue":"5","key":"10.1016\/j.yebeh.2023.109194_b0085","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1523\/JNEUROSCI.23-05-01840.2003","article-title":"Excitatory actions of endogenously released GABA contribute to initiation of ictal epileptiform activity in the developing hippocampus","volume":"23","author":"Dzhala","year":"2003","journal-title":"J Neurosci"},{"issue":"2","key":"10.1016\/j.yebeh.2023.109194_b0090","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/ana.21229","article-title":"Bumetanide enhances phenobarbital efficacy in a neonatal seizure model","volume":"63","author":"Dzhala","year":"2008","journal-title":"Ann Neurol"},{"issue":"3","key":"10.1016\/j.yebeh.2023.109194_b0095","doi-asserted-by":"crossref","first-page":"e57148","DOI":"10.1371\/journal.pone.0057148","article-title":"Bumetanide enhances phenobarbital efficacy in a rat model of hypoxic neonatal seizures","volume":"8","author":"Cleary","year":"2013","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.yebeh.2023.109194_b0100","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1080\/14728222.2020.1762174","article-title":"Preclinical insights into therapeutic targeting of KCC2 for disorders of neuronal hyperexcitability","volume":"24","author":"Duy","year":"2020","journal-title":"Expert Opin Ther Targets"},{"issue":"2","key":"10.1016\/j.yebeh.2023.109194_b0105","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/ana.25959","article-title":"A pilot randomized, controlled, double-blind trial of bumetanide to treat neonatal seizures","volume":"89","author":"Soul","year":"2021","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.yebeh.2023.109194_b0110","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/cne.20972","article-title":"Developmental regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid receptor subunit expression in forebrain and relationship to regional susceptibility to hypoxic\/ischemic injury. I. Rodent cerebral white matter and cortex","volume":"497","author":"Talos","year":"2006","journal-title":"J Comp Neurol"},{"issue":"4","key":"10.1016\/j.yebeh.2023.109194_b0115","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1111\/j.1528-1167.2008.01947.x","article-title":"Talampanel suppresses the acute and chronic effects of seizures in a rodent neonatal seizure model","volume":"50","author":"Aujla","year":"2009","journal-title":"Epilepsia"},{"issue":"24","key":"10.1016\/j.yebeh.2023.109194_b0120","doi-asserted-by":"crossref","first-page":"4814","DOI":"10.1523\/JNEUROSCI.2041-18.2019","article-title":"AMPA receptor dysregulation and therapeutic interventions in a mouse model of CDKL5 deficiency disorder","volume":"39","author":"Yennawar","year":"2019","journal-title":"J Neurosci"},{"issue":"10","key":"10.1016\/j.yebeh.2023.109194_b0125","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1111\/j.1528-1157.1995.tb00954.x","article-title":"NBQX blocks acute and late epileptogenic effects of perinatal hypoxia","volume":"36","author":"Jensen","year":"1995","journal-title":"Epilepsia"},{"issue":"6","key":"10.1016\/j.yebeh.2023.109194_b0130","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/j.0013-9580.2004.69103.x","article-title":"NBQX or topiramate treatment after perinatal hypoxia-induced seizures prevents later increases in seizure-induced neuronal injury","volume":"45","author":"Koh","year":"2004","journal-title":"Epilepsia"},{"issue":"11","key":"10.1016\/j.yebeh.2023.109194_b0135","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1111\/epi.12378","article-title":"AMPA receptor antagonist NBQX attenuates later-life epileptic seizures and autistic-like social deficits following neonatal seizures","volume":"54","author":"Lippman-Bell","year":"2013","journal-title":"Epilepsia"},{"issue":"32","key":"10.1016\/j.yebeh.2023.109194_b0140","doi-asserted-by":"crossref","first-page":"7979","DOI":"10.1523\/JNEUROSCI.1734-08.2008","article-title":"Early alterations of AMPA receptors mediate synaptic potentiation induced by neonatal seizures","volume":"28","author":"Rakhade","year":"2008","journal-title":"J Neurosci"},{"key":"10.1016\/j.yebeh.2023.109194_b0145","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.nbd.2018.05.001","article-title":"Regulation of seizure-induced MeCP2 Ser421 phosphorylation in the developing brain","volume":"116","author":"Rosenberg","year":"2018","journal-title":"Neurobiol Dis"},{"issue":"9","key":"10.1016\/j.yebeh.2023.109194_b0150","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1016\/j.celrep.2018.04.108","article-title":"Early seizures prematurely unsilence auditory synapses to disrupt thalamocortical critical period plasticity","volume":"23","author":"Sun","year":"2018","journal-title":"Cell Rep"},{"issue":"7","key":"10.1016\/j.yebeh.2023.109194_b0155","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1111\/j.1528-1167.2011.03109.x","article-title":"Perampanel: a novel, orally active, noncompetitive AMPA-receptor antagonist that reduces seizure activity in rodent models of epilepsy","volume":"52","author":"Hanada","year":"2011","journal-title":"Epilepsia"},{"issue":"5","key":"10.1016\/j.yebeh.2023.109194_b0160","doi-asserted-by":"crossref","first-page":"e00063","DOI":"10.1002\/prp2.63","article-title":"Effect of perampanel, a novel AMPA antagonist, on benzodiazepine-resistant status epilepticus in a lithium-pilocarpine rat model","volume":"2","author":"Hanada","year":"2014","journal-title":"Pharmacol Res Perspect"},{"issue":"4","key":"10.1016\/j.yebeh.2023.109194_b0165","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1517\/17460441.2014.891580","article-title":"The discovery and development of perampanel for the treatment of epilepsy","volume":"9","author":"Hanada","year":"2014","journal-title":"Expert Opin Drug Discov"},{"issue":"1","key":"10.1016\/j.yebeh.2023.109194_b0170","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/epi.16413","article-title":"Open-label study to investigate the safety and efficacy of adjunctive perampanel in pediatric patients (4 to <12 years) with inadequately controlled focal seizures or generalized tonic-clonic seizures","volume":"61","author":"Fogarasi","year":"2020","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2023.109194_b0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.eplepsyres.2021.106550","article-title":"Efficacy of perampanel in epilepsy patients with autism spectrum disorder","volume":"170","author":"Kanemura","year":"2021","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2023.109194_b0180","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.eplepsyres.2019.02.014","article-title":"Efficacy and tolerability of perampanel in pediatric patients with Dravet syndrome","volume":"154","author":"Yoshitomi","year":"2019","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2023.109194_b0185","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.seizure.2019.12.024","article-title":"The efficacy of perampanel in young children with drug-resistant epilepsy","volume":"75","author":"Chang","year":"2020","journal-title":"Seizure"},{"issue":"4","key":"10.1016\/j.yebeh.2023.109194_b0190","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1007\/s12035-018-1230-6","article-title":"Perampanel but not amantadine prevents behavioral alterations and epileptogenesis in pilocarpine rat model of status epilepticus","volume":"56","author":"Mohammad","year":"2019","journal-title":"Mol Neurobiol"},{"issue":"9","key":"10.1016\/j.yebeh.2023.109194_b0195","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.biopsych.2019.12.025","article-title":"Low-dose perampanel rescues cortical gamma dysregulation associated with parvalbumin interneuron GluA2 upregulation in epileptic Syngap1(+\/-) mice","volume":"87","author":"Sullivan","year":"2020","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.yebeh.2023.109194_b0200","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.682767","article-title":"Perampanel reduces hyperthermia-induced seizures in Dravet syndrome mouse model","volume":"12","author":"Ho","year":"2021","journal-title":"Front Pharmacol"},{"issue":"6","key":"10.1016\/j.yebeh.2023.109194_b0205","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/ana.410290610","article-title":"Epileptogenic effect of hypoxia in the immature rodent brain","volume":"29","author":"Jensen","year":"1991","journal-title":"Ann Neurol"},{"issue":"4","key":"10.1016\/j.yebeh.2023.109194_b0210","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/j.1528-1167.2011.02992.x","article-title":"Development of later life spontaneous seizures in a rodent model of hypoxia-induced neonatal seizures","volume":"52","author":"Rakhade","year":"2011","journal-title":"Epilepsia"},{"issue":"10","key":"10.1016\/j.yebeh.2023.109194_b0215","doi-asserted-by":"crossref","first-page":"e1006398","DOI":"10.1371\/journal.pgen.1006398","article-title":"Fine mapping of a Dravet syndrome modifier locus on mouse chromosome 5 and candidate gene analysis by RNA-Seq","volume":"12","author":"Hawkins","year":"2016","journal-title":"PLoS Genet"},{"issue":"2","key":"10.1016\/j.yebeh.2023.109194_b0220","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/gbb.12099","article-title":"Mapping genetic modifiers of survival in a mouse model of Dravet syndrome","volume":"13","author":"Miller","year":"2014","journal-title":"Genes Brain Behav"},{"key":"10.1016\/j.yebeh.2023.109194_b0225","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.69293","article-title":"Corticohippocampal circuit dysfunction in a mouse model of Dravet syndrome","volume":"11","author":"Mattis","year":"2022","journal-title":"Elife"},{"key":"10.1016\/j.yebeh.2023.109194_b0230","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jneumeth.2015.09.023","article-title":"Models of hypoxia and ischemia-induced seizures","volume":"260","author":"Sun","year":"2016","journal-title":"J Neurosci Methods"},{"issue":"5","key":"10.1016\/j.yebeh.2023.109194_b0235","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1002\/acn3.413","article-title":"Screening of conventional anticonvulsants in a genetic mouse model of epilepsy","volume":"4","author":"Hawkins","year":"2017","journal-title":"Ann Clin Transl Neurol"},{"issue":"13","key":"10.1016\/j.yebeh.2023.109194_b0240","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1523\/JNEUROSCI.2370-19.2020","article-title":"Interneuron desynchronization precedes seizures in a mouse model of Dravet syndrome","volume":"40","author":"Tran","year":"2020","journal-title":"J Neurosci"},{"issue":"9","key":"10.1016\/j.yebeh.2023.109194_b0245","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.seizure.2014.06.001","article-title":"Pharmacodynamic and pharmacokinetic interactions of perampanel and other antiepileptic drugs in a rat amygdala kindling model","volume":"23","author":"Wu","year":"2014","journal-title":"Seizure"},{"issue":"1","key":"10.1016\/j.yebeh.2023.109194_b0250","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/pr.2012.151","article-title":"Antiepileptic effects of levetiracetam in a rodent neonatal seizure model","volume":"73","author":"Talos","year":"2013","journal-title":"Pediatr Res"},{"issue":"20","key":"10.1016\/j.yebeh.2023.109194_b0255","doi-asserted-by":"crossref","first-page":"8154","DOI":"10.1523\/JNEUROSCI.21-20-08154.2001","article-title":"Decreased glutamate receptor 2 expression and enhanced epileptogenesis in immature rat hippocampus after perinatal hypoxia-induced seizures","volume":"21","author":"Sanchez","year":"2001","journal-title":"J Neurosci"},{"issue":"2","key":"10.1016\/j.yebeh.2023.109194_b0260","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/sj.bjp.0706301","article-title":"Potential of ketamine and midazolam, individually or in combination, to induce apoptotic neurodegeneration in the infant mouse brain","volume":"146","author":"Young","year":"2005","journal-title":"Br J Pharmacol"},{"issue":"5","key":"10.1016\/j.yebeh.2023.109194_b0265","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1111\/epi.13365","article-title":"Anticonvulsant drug-induced cell death in the developing white matter of the rodent brain","volume":"57","author":"Kaushal","year":"2016","journal-title":"Epilepsia"},{"issue":"7","key":"10.1016\/j.yebeh.2023.109194_b0270","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.ijdevneu.2009.06.010","article-title":"Prolonged exposure to ketamine increases neurodegeneration in the developing monkey brain","volume":"27","author":"Zou","year":"2009","journal-title":"Int J Dev Neurosci"},{"key":"10.1016\/j.yebeh.2023.109194_b0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.105245","article-title":"Brain pathology caused in the neonatal macaque by short and prolonged exposures to anticonvulsant drugs","volume":"149","author":"Noguchi","year":"2021","journal-title":"Neurobiol Dis"},{"issue":"2","key":"10.1016\/j.yebeh.2023.109194_b0280","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.pediatrneurol.2007.04.003","article-title":"Neonatal seizures: multicenter variability in current treatment practices","volume":"37","author":"Bartha","year":"2007","journal-title":"Pediatr Neurol"},{"issue":"2","key":"10.1016\/j.yebeh.2023.109194_b0285","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.pediatrneurol.2011.11.006","article-title":"Neonatal seizures: treatment practices among term and preterm infants","volume":"46","author":"Glass","year":"2012","journal-title":"Pediatr Neurol"},{"issue":"2","key":"10.1016\/j.yebeh.2023.109194_b0290","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/apa.12812","article-title":"Systematic review of neonatal seizure management strategies provides guidance on anti-epileptic treatment","volume":"104","author":"Hellstrom-Westas","year":"2015","journal-title":"Acta Paediatr"},{"issue":"3","key":"10.1016\/j.yebeh.2023.109194_b0295","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/ana.1122","article-title":"Topiramate blocks perinatal hypoxia-induced seizures in rat pups","volume":"50","author":"Koh","year":"2001","journal-title":"Ann Neurol"},{"issue":"50","key":"10.1016\/j.yebeh.2023.109194_b0300","doi-asserted-by":"crossref","first-page":"18211","DOI":"10.1523\/JNEUROSCI.4838-11.2011","article-title":"Hypoxia-induced neonatal seizures diminish silent synapses and long-term potentiation in hippocampal CA1 neurons","volume":"31","author":"Zhou","year":"2011","journal-title":"J Neurosci"},{"issue":"1","key":"10.1016\/j.yebeh.2023.109194_b0305","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1159\/000499084","article-title":"Topiramate plus cooling for hypoxic-ischemic encephalopathy: a randomized, controlled, multicenter, double-blinded trial","volume":"116","author":"Nunez-Ramiro","year":"2019","journal-title":"Neonatology"},{"issue":"8","key":"10.1016\/j.yebeh.2023.109194_b0310","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1080\/14767058.2017.1304536","article-title":"Safety and efficacy of topiramate in neonates with hypoxic ischemic encephalopathy treated with hypothermia (NeoNATI): a feasibility study","volume":"31","author":"Filippi","year":"2018","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"Suppl 2","key":"10.1016\/j.yebeh.2023.109194_b0315","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1469-8749.2011.03965.x","article-title":"Molecular genetics of Dravet syndrome","volume":"53","author":"De Jonghe","year":"2011","journal-title":"Dev Med Child Neurol"},{"issue":"22","key":"10.1016\/j.yebeh.2023.109194_b0320","doi-asserted-by":"crossref","first-page":"5903","DOI":"10.1523\/JNEUROSCI.5270-06.2007","article-title":"Nav1.1 localizes to axons of parvalbumin-positive inhibitory interneurons: a circuit basis for epileptic seizures in mice carrying an Scn1a gene mutation","volume":"27","author":"Ogiwara","year":"2007","journal-title":"J Neurosci"},{"issue":"9","key":"10.1016\/j.yebeh.2023.109194_b0325","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1038\/nn1754","article-title":"Reduced sodium current in GABAergic interneurons in a mouse model of severe myoclonic epilepsy in infancy","volume":"9","author":"Yu","year":"2006","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.yebeh.2023.109194_b0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.pediatrneurol.2017.01.025","article-title":"Optimizing the diagnosis and management of Dravet syndrome: recommendations from a North American consensus panel","volume":"68","author":"Wirrell","year":"2017","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.yebeh.2023.109194_b0335","doi-asserted-by":"crossref","DOI":"10.1177\/2329048X211050711","article-title":"Long-term efficacy of perampanel in a child with Dravet syndrome","volume":"8","author":"Turon-Vinas","year":"2021","journal-title":"Child Neurol Open"},{"issue":"3","key":"10.1016\/j.yebeh.2023.109194_b0340","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0306-20.2021","article-title":"Enhanced synaptic transmission in the extended amygdala and altered excitability in an extended amygdala to brainstem circuit in a Dravet syndrome mouse model","volume":"8","author":"Yan","year":"2021","journal-title":"eNeuro"},{"key":"10.1016\/j.yebeh.2023.109194_b0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105128","article-title":"Cannabidiol inhibits febrile seizure by modulating AMPA receptor kinetics through its interaction with the N-terminal domain of GluA1\/GluA2","volume":"161","author":"Yu","year":"2020","journal-title":"Pharmacol Res"}],"container-title":["Epilepsy &amp; Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505023001130?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505023001130?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:50:22Z","timestamp":1761504622000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505023001130"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":69,"alternative-id":["S1525505023001130"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2023.109194","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-seizure efficacy of perampanel in two established rodent models of early-life epilepsy","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2023.109194","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109194"}}